Post-approval studies (Phase 4)Not Yet RecruitingNCT05452928What this trial is testingAciclovir Versus Placebo for HSV-2 MeningitisWho this might be right forHerpes Simplex 2Meningitis, Viral Jacob Bodilsen 150
Post-approval studies (Phase 4)Study completedNCT01346475What this trial is testingRandomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2Who this might be right forGenital Herpes University of Washington 50
Post-approval studies (Phase 4)Study completedNCT00116844What this trial is testingVALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.Who this might be right forInfections, Herpesviridae GlaxoSmithKline 73
Large-scale testing (Phase 3)Ended earlyNCT05305040What this trial is testingStudy of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell TransplantWho this might be right forAdenovirus InfectionBK Virus InfectionCytomegalovirus Infections+3 more AlloVir 451
Large-scale testing (Phase 3)Study completedNCT00560755What this trial is testingSafety Study of ProQuad® rHA in Infants (V221-037)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 3,388
Early research (Phase 1)Ended earlyNCT04762511What this trial is testingA Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 YearsWho this might be right forHerpes Simplex GlaxoSmithKline 17
Early research (Phase 1)Study completedNCT06698575What this trial is testingAssess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital HerpesWho this might be right forRecurrent Genital Herpes Simplex Type 2 Assembly Biosciences 103
Testing effectiveness (Phase 2)Study completedNCT00405821What this trial is testingAcyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in UgandaWho this might be right forHIV InfectionsHerpes Genitalis National Institute of Allergy and Infectious Diseases (NIAID) 440
Large-scale testing (Phase 3)UnknownNCT01068015What this trial is testing(Men Who Have Sex With Men) MSM Community Intervention TrialWho this might be right forHIVSyphilisHerpesvirus 2, Human National Center for AIDS/STD Control and Prevention, China CDC 3,214
Not applicableStudy completedNCT00112593What this trial is testingFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more Fred Hutchinson Cancer Center 5
Large-scale testing (Phase 3)Study completedNCT00076232What this trial is testingAcyclovir to Help Prevent HIV Infection in People With Genital HerpesWho this might be right forHIV InfectionsHIV SeronegativityHerpes Genitalis National Institute of Allergy and Infectious Diseases (NIAID) 3,682
Testing effectiveness (Phase 2)Study completedNCT02114060What this trial is testingDose Ranging Safety and Efficacy of Therapeutic HSV-2 VaccineWho this might be right forGenital Herpes Simplex Type 2 Genocea Biosciences, Inc. 310
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Large-scale testing (Phase 3)Study completedNCT00465205What this trial is testingHSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsWho this might be right forHIV InfectionsHerpes SimplexSexually Transmitted Diseases University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT02030301What this trial is testingSafety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in AdultsWho this might be right forGenital Herpes Simplex Type 2 Vical 165
Not applicableStudy completedNCT03868644What this trial is testingThe Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in KenyaWho this might be right forHIV/AIDSHSV-2 Infection Abdul Latif Jameel Poverty Action Lab 10,646
Post-approval studies (Phase 4)Study completedNCT00306293What this trial is testingVALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2Who this might be right forHerpes Labialis GlaxoSmithKline 70
Testing effectiveness (Phase 2)Ended earlyNCT05703607What this trial is testingLearn About a Modified RNA Vaccine Against Shingles in Healthy AdultsWho this might be right forShinglesHerpes Zoster InfectionHuman Pfizer 484
Not applicableStudy completedNCT00899496What this trial is testingLaboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy ParticipantsWho this might be right forCancer Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Study completedNCT04165122What this trial is testingMonoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 InfectionWho this might be right forHerpes Genitalis Heidelberg ImmunoTherapeutics GmbH 122